Using data from the Southern California Children's Health Study (CHS), we previously reported that the two most common promoter haplotypes in NOS2 significantly affects FeNO level in children [15], and were also associated with asthma risk and lung function growth in children [16]. This evidence concerns the gene NOS2 and asthma.